Floatz logo

LITHIUM, ELEMENTAL

Dementia

University of ChileSmall moleculePhase 4 / ApprovedActive
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
81/ 100

Competitive context

43 Active assets in the Dementia cohort.

Asset / SponsorPhaseRating
Risperdal
Hannover Medical School
Phase 4BBB
CITALOPRAM
Hannover Medical School
Phase 4BBB
Cipralex
Ohio State University
Phase 4BB
Namenda
Zealand University Hospital
Phase 4BB
Galantamine Hydrobromide
Janssen Pharmaceutica N.V., Belgium
Phase 3BB

View all 50 →

Same molecule, other indications

LITHIUM, ELEMENTAL is also rated in:

bipolar I disorderDormant
BBB
Indicative ·
77 / 100
View asset →
manic bipolar affective disorderDormant
BBB
Indicative ·
75 / 100
View asset →
bipolar depressionDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →